Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells - PubMed (original) (raw)
. 1996 Nov 29;271(48):30835-9.
doi: 10.1074/jbc.271.48.30835.
Affiliations
- PMID: 8940066
- DOI: 10.1074/jbc.271.48.30835
Free article
Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells
K Datta et al. J Biol Chem. 1996.
Free article
Abstract
The Akt protooncogene encodes a serine-threonine protein kinase which is activated by growth factor-generated signals that are transduced via the phosphatidylinositol 3'-kinase (PI3-K). Earlier studies suggested that the activation of Akt by PI3-K may be mediated by the binding of D3-phosphorylated phosphoinositides to the Akt pleckstrin homology (PH) domain. On the basis of these studies, it was hypothesized that Akt is a direct PI3-K target. To test this hypothesis, we reconstituted the pathway of Akt activation in baculovirus-infected Sf9 cells. The results showed that Akt, which is normally catalytically inactive in these cells, was activated when coexpressed with the activated PI3-K. Moreover, they showed that activated forms of c-Ha-ras (v-Ha-ras) and c-src (v-src or srcY527F), two molecules that transduce growth factor-generated signals, also activate Akt in a PI3-K-dependent manner in Sf9 as well as NIH 3T3 cells. The activation of Akt by both growth factors and v-ras and v-src (or srcY527F) depends on the integrity of the Akt PH domain and carboxyl-terminal tail. These results show that Akt activation via the PI3-K can be faithfully reproduced in baculovirus-infected Sf9 cells. The same results support the hypothesis that Akt is a direct target of the PI3-K and identify cytoplasmic signaling molecules that may contribute to the transduction of PI3-K/Akt activation signals.
Similar articles
- Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner.
Sohara Y, Ishiguro N, Machida K, Kurata H, Thant AA, Senga T, Matsuda S, Kimata K, Iwata H, Hamaguchi M. Sohara Y, et al. Mol Biol Cell. 2001 Jun;12(6):1859-68. doi: 10.1091/mbc.12.6.1859. Mol Biol Cell. 2001. PMID: 11408591 Free PMC article. - Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt.
Hakak Y, Hsu YS, Martin GS. Hakak Y, et al. Oncogene. 2000 Jun 29;19(28):3164-71. doi: 10.1038/sj.onc.1203655. Oncogene. 2000. PMID: 10918571 - AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.
Liu AX, Testa JR, Hamilton TC, Jove R, Nicosia SV, Cheng JQ. Liu AX, et al. Cancer Res. 1998 Jul 15;58(14):2973-7. Cancer Res. 1998. PMID: 9679957 - A target for phosphoinositide 3-kinase: Akt/PKB.
Bos JL. Bos JL. Trends Biochem Sci. 1995 Nov;20(11):441-2. doi: 10.1016/s0968-0004(00)89097-0. Trends Biochem Sci. 1995. PMID: 8578585 Review. No abstract available. - AKT-independent PI3-K signaling in cancer - emerging role for SGK3.
Bruhn MA, Pearson RB, Hannan RD, Sheppard KE. Bruhn MA, et al. Cancer Manag Res. 2013 Aug 26;5:281-92. doi: 10.2147/CMAR.S35178. eCollection 2013. Cancer Manag Res. 2013. PMID: 24009430 Free PMC article. Review.
Cited by
- Akt kinase C-terminal modifications control activation loop dephosphorylation and enhance insulin response.
Chan TO, Zhang J, Tiegs BC, Blumhof B, Yan L, Keny N, Penny M, Li X, Pascal JM, Armen RS, Rodeck U, Penn RB. Chan TO, et al. Biochem J. 2015 Oct 1;471(1):37-51. doi: 10.1042/BJ20150325. Epub 2015 Jul 22. Biochem J. 2015. PMID: 26201515 Free PMC article. - beta1-Integrins induce phosphorylation of Akt on serine 473 independently of focal adhesion kinase and Src family kinases.
Velling T, Nilsson S, Stefansson A, Johansson S. Velling T, et al. EMBO Rep. 2004 Sep;5(9):901-5. doi: 10.1038/sj.embor.7400234. EMBO Rep. 2004. PMID: 15309026 Free PMC article. - Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application.
Yan W, Lakkaniga NR, Carlomagno F, Santoro M, McDonald NQ, Lv F, Gunaganti N, Frett B, Li HY. Yan W, et al. J Med Chem. 2019 Feb 28;62(4):1731-1760. doi: 10.1021/acs.jmedchem.8b01092. Epub 2018 Sep 19. J Med Chem. 2019. PMID: 30188734 Free PMC article. - The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis.
Jiang K, Coppola D, Crespo NC, Nicosia SV, Hamilton AD, Sebti SM, Cheng JQ. Jiang K, et al. Mol Cell Biol. 2000 Jan;20(1):139-48. doi: 10.1128/MCB.20.1.139-148.2000. Mol Cell Biol. 2000. PMID: 10594016 Free PMC article. - Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells.
Matthews JA, Belof JL, Acevedo-Duncan M, Potter RL. Matthews JA, et al. Mol Cell Biochem. 2007 Apr;298(1-2):109-23. doi: 10.1007/s11010-006-9358-5. Epub 2006 Nov 30. Mol Cell Biochem. 2007. PMID: 17136481
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous